Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds RSS Feed PharmiWeb Candidate Blog RSS Feed PharmiWeb Client Blog


Press Release

Overview of Japanese Generic Drug Market 2016 - Research and Markets

Research and Markets
Posted on: 20 Oct 16

Research and Markets has announced the addition of the "The Overview of Japanese Generic Drug Market" report to their offering.

This report talks about the overview of Japanese generic drug market.

The readers will understand overall climate surrounding generic market in Japan. The report covers related regulations, generics's share in Japan, market size, primary makers, market trend, and updated situation about biosimilars and authorized generics.

The share of generics in the prescription drugs market has been dramatically increasing in terms of both volume and value. The recent volume share was 60.1% in the 2nd quarter in 2016. This increase has been particularly pronounced since 2007 due to government measures devised to increase the use of generics.

Key Topics Covered:

1. Summary

2. Definition of Generic Drugs

3. Laws and Regulations Pertaining to Generics

4. NHI Drug Price

5. Share of Generics in Prescription Drugs Market

6. Market Size

7. Principal Industry Association

8. Sales of Major Japanese Generic Companies

9. Primary Generic Manufacturers

10. Overview of Leading Japanese Generics Companies

11. Current Market Environment Conditions

12. Considerations by Company Type

13. Government Measures to Promote the Use of Generics

14. Biosimilars

15. Authorized Generics

16. Future Outlook

Companies Mentioned

  • Actavis
  • Boehringer Ingelheim
  • Daiichi Sankyo
  • Hospira
  • Lupin
  • Meiji
  • Mochida
  • Mylan
  • Nichi-Iko
  • Nippon Chemiphar
  • Nippon Kayaku,Kissei
  • Ohara
  • Sandoz
  • Sanwa
  • Sawai
  • Teva
  • Towa
  • Zydus

For more information about this report visit

View source version on

Business Wire

Last updated on: 20/10/2016

Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.